Anorit Medical ApS: Company Profile

Background

Overview

Anorit Medical ApS is a Danish MedTech startup established in 2024, dedicated to enhancing survival rates during out-of-hospital cardiac arrests. The company is developing an innovative ventilation device designed for layperson use, aiming to improve bystander intervention by providing high-quality air without direct contact with the patient. This approach addresses the challenges associated with traditional mouth-to-mouth ventilation, which can deter bystanders due to intimacy barriers and complexity.

Mission and Vision

Anorit Medical's mission is to empower individuals to become lifesavers by facilitating effective and hygienic resuscitation efforts during cardiac emergencies. The company's vision is to significantly increase survival rates from out-of-hospital cardiac arrests by providing a user-friendly, non-invasive ventilation solution that complements existing resuscitation practices.

Primary Area of Focus

The company's primary focus is on the development and commercialization of a novel ventilation device tailored for use by untrained bystanders during cardiac arrest situations. This device aims to simplify the resuscitation process, making it more accessible and effective in emergency scenarios.

Industry Significance

In Europe, approximately 350,000 cases of out-of-hospital cardiac arrest occur annually, with survival rates remaining low. Anorit Medical's innovative approach has the potential to revolutionize emergency response by enhancing the quality and accessibility of bystander interventions, thereby improving overall survival outcomes.

Key Strategic Focus

Core Objectives

Product Development: Finalize the design and functionality of the ventilation device to ensure it meets medical standards and user requirements.

Market Penetration: Introduce the device to healthcare providers, emergency response teams, and the general public to facilitate widespread adoption.

Regulatory Compliance: Navigate the regulatory landscape to obtain necessary approvals for medical device distribution and use.

Specific Areas of Specialization

Medical Device Innovation: Focus on creating user-friendly, non-invasive medical devices that address critical needs in emergency care.

Bystander Training and Education: Develop educational materials and programs to train the public in effective use of the device during cardiac emergencies.

Key Technologies Utilized

Non-Invasive Ventilation Mechanisms: Employ advanced technologies to deliver high-quality air without direct patient contact, enhancing hygiene and ease of use.

User-Centric Design: Incorporate ergonomic and intuitive design principles to ensure the device is accessible to individuals without medical training.

Primary Markets Targeted

Healthcare Providers: Hospitals and clinics that can integrate the device into their emergency response protocols.

Emergency Response Teams: Paramedics and first responders who can utilize the device in pre-hospital care settings.

General Public: Individuals trained in basic life support who can use the device during out-of-hospital cardiac arrest incidents.

Financials and Funding

Funding History

Anorit Medical has secured funding through various channels, including participation in the Life Science Pitch Competition 2025 and support from the BioInnovation Institute's Venture Lab program. These investments have been instrumental in advancing the company's product development and operational capabilities.

Total Funds Raised

While specific figures are not publicly disclosed, the company has received significant support from both public and private investors, reflecting confidence in its mission and potential impact.

Notable Investors

Life Science Pitch Competition 2025: Provided initial funding and exposure to the healthcare investment community.

BioInnovation Institute's Venture Lab: Offered substantial financing and dedicated support to transition from prototype to production.

Intended Utilization of Capital

Product Development: Refine and finalize the ventilation device to meet medical standards and user expectations.

Regulatory Approvals: Navigate the regulatory process to obtain necessary certifications for medical device distribution.

Market Expansion: Increase production capacity and expand marketing efforts to reach a broader audience.

Pipeline Development

Key Pipeline Candidates

Ventilation Device: Currently in the prototype phase, the device is designed to provide high-quality air during cardiac arrest without direct patient contact.

Stages of Development

Prototype Testing: Completed initial user testing to gather feedback and make necessary design adjustments.

Clinical Trials: Planning to conduct trials to assess the device's effectiveness in real-world emergency scenarios.

Target Conditions

Out-of-Hospital Cardiac Arrest: Focus on improving survival rates for individuals experiencing cardiac arrest outside of hospital settings.

Anticipated Milestones

Prototype Finalization: Expected within the next 6 months, incorporating feedback from initial testing.

Regulatory Approval: Aiming for certification within the next 12 months to facilitate market entry.

Technological Platform and Innovation

Proprietary Technologies

Non-Invasive Ventilation Mechanism: A unique system that delivers air without direct contact, enhancing hygiene and ease of use.

Significant Scientific Methods

User-Centered Design: Employing design thinking methodologies to create a device that is intuitive and accessible to non-medical users.

Leadership Team

Sotiria Athanasiadou – CEO & Co-founder

A pharmacist with a Master's degree in "Medicines and Society," Sotiria has experience in global quality and medical affairs within the medical device industry. She has also founded and grown a volunteering student organization.

Minik Nørreslet – CTO & Co-founder

An experienced osteopath with studies in mechanical engineering, Minik has owned and developed businesses in physiotherapy and osteopathy.

Andreas Konradsen – CPO & Co-founder

An industrial designer from the Royal Danish Academy of Architecture, Design, and Conservation, Andreas has 10 years of experience in product development and previously served as CTO in a medical device startup.

Market and Competitor Analysis

Market Insights and Dynamics

The market for emergency medical devices, particularly those designed for layperson use during cardiac arrest, is growing due to increasing awareness of sudden cardiac events and the importance of immediate intervention. Innovations that simplify resuscitation processes are gaining traction among healthcare providers and emergency response teams.

Competitors

Mechanical CPR: Develops chest compression devices for cardiac patients.

Medicalcooling: Offers ventilators that double the survival rate of cardiac arrest.

Airchill + Head Sport Health: Provides technology that prevents brain damage and detects other injuries.

Compact Medical Solutions: Disrupts a 60-year-old industry with a novel medical device.

Respirana, Inc.: Develops an innovative emergency ventilator for advanced CPR.

CoLabs Medical: Focuses on developing an emergency airway and ventilation system.

Heroic-Faith Medical Science: Innovates in automatic early symptom awareness for pulmonary conditions.

Neurescue: Develops cardiovascular devices to help emergency patients.

SVASTEK: Focuses on healing through innovations in medical technology.

Airway Medical Ltd: The world's first and only sustainable medical device company.

Strategic Collaborations and Partnerships

Anorit Medical has been accepted into the BioInnovation Institute's Venture Lab program, providing significant financing and dedicated support to transition from prototype to production.

Operational Insights

Anorit Medical's focus on non-invasive, user-friendly design differentiates it from competitors that may offer more complex or invasive solutions. The company's commitment to sustainability and user education further strengthens its market position.

Strategic Opportunities and Future Directions

The company plans to expand its product line to include additional emergency medical devices and explore international markets to increase its impact on global survival rates from cardiac arrest.